ACM
TNYA icon

ADAR1 Capital Management’s Tenaya Therapeutics TNYA Stock Holding History

ADAR1 Capital Management’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.04M Buy
1,507,800
+2,500
+0.2% +$1.84K 0.06% 155
2025
Q4 		$1.07M Buy
+1,505,300
New +$2.05M 0.08% 128

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ADAR1 Capital Management's TNYA Position: Q1 2026 in Review

ADAR1 Capital Management increased its Tenaya Therapeutics (TNYA) stake by 0.17% in Q1 2026, buying an estimated $1.84K and bringing the position to 1,507,800 shares worth $1.04M. The position accounts for 0.06% of the portfolio, ranked #155.

ADAR1 Capital Management first reported a position in TNYA in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.07M in Q4 2025. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • ADAR1 Capital Management held 1,507,800 shares of Tenaya Therapeutics worth $1.04M as of Q1 2026.
  • ADAR1 Capital Management bought 2,500 Tenaya Therapeutics shares in Q1 2026, an estimated $1.84K.
  • Tenaya Therapeutics made up 0.06% of ADAR1 Capital Management's portfolio in Q1 2026, its #155 holding.
  • ADAR1 Capital Management first reported a position in Tenaya Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • ADAR1 Capital Management's Tenaya Therapeutics position peaked at $1.07M in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on ADAR1 Capital Management's 13F filing for Q1 2026, filed 18 May 2026.